The Joints and Connective Tissue

  • John J. Dallman


Diseases involving the joints and connective tissue comprise one of the most prevalent categories of patient care provided by family physicians. This chapter discusses the core problems of rheumatoid arthritis, Osteoarthritis, gout, fibrositis/ myositis, and arthralgia. Additionally, other problems such as connective tissue disorders, crystalline, seronegative and infectious arthritides, vascular syndromes involving joints, and others are discussed.


Rheumatoid Arthritis Uric Acid Synovial Fluid Family Physician Psoriatic Arthritis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Rosenblatt RA, Cherkin DC, Schneeweiss R, et al. The structure and content of family practice: current status and future trends. J Fam Pract 1982; 15: 681–722.PubMedGoogle Scholar
  2. 2.
    Becker MA, Seegmiller JE. Genetic aspects of gout. Annu Rev Med 1974; 25: 15–28.PubMedCrossRefGoogle Scholar
  3. 3.
    Fessel WJ. Hyperuricemia in health and disease. Semin Arthritis Rheum 1972; 1: 275–99.PubMedCrossRefGoogle Scholar
  4. 4.
    Rodnan GP, Schumacher HR. Primer on the rheumatic diseases. 8th ed. Atlanta: Arthritis Foundation, 1983.Google Scholar
  5. 5.
    Calin A. Degenerative joint disease. Am Fam Physician 1986; 33: 167–72.PubMedGoogle Scholar
  6. 6.
    O’Sullivan JB, Cathcart ES. The prevalence of rheumatoid arthri-tis. Ann Intern Med 1972; 76: 573–7.PubMedCrossRefGoogle Scholar
  7. 7.
    Bjarnason D, Dlesk A, Goldberg JW, et al. Early rheumatoid arthritis. Postgrad Med 1986; 79: 46–61.PubMedGoogle Scholar
  8. 8.
    McCarty GA. Update on laboratory studies and relationship to rheumatic and allergic diseases. Ann Allergy 1985; 55: 421–33.PubMedGoogle Scholar
  9. 9.
    Simon LS, Mills JA: Non-steroidal anti-inflammatory drugs. N Engl J Med 1980;302: 1179–84, 1237–42.Google Scholar
  10. 10.
    Bunch TW, O’Duffy JD. Disease modifying drugs for progressive rheumatoid arthritis. Mayo Clin Proc 1980; 55: 161–79.PubMedGoogle Scholar
  11. 11.
    Dahl SL, Coleman ML, Williams HJ, et al. Lack of correlation between blood gold concentrations and clinical response in patients with definite or classic rheumatoid arthritis receiving auronofin or gold sodium thiomalate. Arthritis Rheum 1985; 28: 1211–18.PubMedCrossRefGoogle Scholar
  12. 12.
    Goldenburg DL, Cohen AS. Acute infectious arthritis: a review of patients with non-gonococcal joint infections. Am J Med 1976; 60: 369–76.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1988

Authors and Affiliations

  • John J. Dallman

There are no affiliations available

Personalised recommendations